Posted in | News

Mitsubishi Electric to Introduce New Lineup of NEXIEZ Elevators in India

Mitsubishi Electric Corporation announced today the Indian-market launch of NEXIEZ-LITE, a new lineup in the company’s NEXIEZ global series of elevators, for low- and mid-rise residential and office buildings beginning April 14. Annual sales of 1,000 units are targeted by 2016.

Main Features

Standardized functions and specifications for India

  • Basic features suitable for low- and mid-rise buildings in India, helping to reduce lead-time while strengthening price competitiveness.
  • Mitsubishi Emergency Landing Device (MELD)* and safety functions such as Multi-beam Door Sensor** are standard-equipped.
  • Three types of car designs*** matched to architectural designs and colors suited to Indian tastes.

Energy savings

  • Gearless traction machine using a permanent magnetic motor reduces power consumption by 20% compared to inverter-controlled worm traction machines.
  • LEDs for car lighting reduce power consumption by 75% compared to traditional incandescent bulbs.

* Mitsubishi Emergency Landing Device (MELD)
In the event that passengers become trapped in a car due to a power failure, etc., MELD automatically checks the elevator status and then moves the car to the nearest floor using its rechargeable battery.

** Multi-beam Door Sensor
As the elevator doors close, a sensor uses multiple infrared beams to monitor the entire doorway. If any passenger/object entering/exiting the car is detected, the doors open immediately.

*** Car designs
Three newly designed car ceilings blend harmoniously with Indian architectural designs.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.